【レポートの概要(一部)】
1. Report Overview
1.1 Overview of Findings: World Market Overview 2015 to 2026
1.2 Why You Should Read This Report
1.3 How This Report Delivers: Chapter Outlines
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About visiongain
2. Introduction to Parkinson’s Disease and its Treatments
2.1 What Causes Parkinson’s?
2.2 Motor Symptoms of Parkinson’s Disease
2.2.1 Tremor: The First Sign of PD
2.2.2 Uncontrolled Muscle Contractions Cause Rigidity
2.2.3 Bradykinesia: The Most Characteristic Feature of Parkinson’s
2.2.4 Postural Instability Manifests as PD Progresses
2.3 Neuropsychiatric Symptoms are Common in PD Patients
2.3.1 Behavioural Deficits are Often the Most Widespread
2.3.2 Cognitive Impairment can Impede Daily Tasks
2.3.3 Autonomic Dysfunction: Another Common Occurrence
2.4 Other Symptoms Associated with Parkinson’s
2.5 Parkinson’s Disease: Diagnosis and Treatment
2.5.1 Diagnosis is Difficult
2.5.2 Treatment Options – Therapeutic Classes
3. Parkinson’s Disease: World Drugs Market, 2016-2026
3.1 Sales of the Overall World PD Drugs Market, 2015-2026
3.2 Parkinson’s Disease: Market Segmentation, 2015
3.3 Overall PD Drug Market: Commercial Drivers and Restraints
3.4 Dopaminergic Agents: Foundation of PD Treatment
3.4.1 Levodopa Therapy
3.4.2 Patent Expiries Affect the Market
3.4.3 New Levodopa Therapies on the Horizon
3.4.4 Dopaminergic Agents: Market Projections to 2026
3.5 Dopamine Receptor Agonists: The Leading Class in 2016
3.5.1 Dopamine Agonists: A Front Line Drug
3.5.2 Advantages over L-Dopa Therapy
3.5.3 Leading Drugs in the Segment
3.5.4 A Healthy R&D Pipeline
3.5.5 Dopamine Receptor Agonists: Market Projections, 2016-2026
3.6 Catechol-O-Methyl Transferase (COMT) Inhibitors: A Popular Choice of Treatment
3.6.1 Entacapone: The Leading Drug in this Segment
3.6.2 Commercial Scope for COMT Inhibitors
3.6.3 COMT Inhibitors: Market Projections, 2016-2026
3.7 Are Monoamine Oxidase–B (MAO-B) Inhibitors Better Than COMT?
3.7.1 MAO-B Inhibitor Therapeutics in the Market
3.7.2 New MAO-B Products in Development
3.7.3 MAO-B Inhibitors: Market Projections, 2016-2026
3.7.4 Other Therapeutic Options: A Growing Opportunity
3.7.5 Generic Erosion in the PD Market
3.7.6 A Broad and Diverse Pharmaceutical Segment
3.7.7 Other Non-medication PD Therapies
3.7.8 The Pipeline Offers Disease Modifying Potential
3.7.9 Other Mechanisms of Action: Market Projections, 2016-2026
4. Leading Companies in the PD Drug Market, 2016
4.1 PD: Novartis sales of Stalevo/Comtan
4.1.1 Market Forecast for Comtan/Stalevo, 2016-2026
4.2 Teva’s Azilect: Past, Present and Future
4.2.1 Market Forecast for Azilect, 2015-2026
4.3 UCB’s Leading Neupro Patch Drug
4.3.1 Market Forecast for Neupro, 2016-2026
4.4 Other Market Players
5. The Leading National Markets, 2016-2026
5.1 Regional Breakdown of the World PD Drug Market, 2016
5.2 The World PD Drug Market: Regional Forecasts to 2026
5.3 The PD Drug Market in the US: The Largest Single National Market
5.3.1 Market Projections for the US, 2015-2026
5.4 The PD Drug Market in the Five Leading European National Markets (EU5), 2016-2026
5.4.1 Market Projections for the EU5, 2016-2026
5.4.2 EU5 Breakdown by Country, 2016
5.4.3 Market Projection for EU5 Countries, Regional Breakdown
5.4.4 Germany: The Largest EU5 Market
5.4.5 France: Strong Healthcare System – What’s Possible There?
5.4.6 UK’s Spending Restrictions Affect the PD Drugs Market
5.4.7 Spain – What Effects Will Austerity Have on PD Drug Sales?
5.4.8 The PD Drug Market in Italy: Rising and Ageing Population
5.5 Japan has the Highest Proportion of Over-65s in the World
5.5.1 Predictions for Japanese PD Drug Market, 2016-2026
5.6 PD Drug Market in Emerging Countries: Brazil, Russia, India and China (BRIC)
5.6.1 Breakdown of BRIC Revenues by Country, 2016
5.6.2 Market Projections for BRIC Nations’ PD Drug Sales, 2016-2026
5.6.3 Brazil’s Rapid Growth of the Pharma Market – What’s the Future?
5.6.4 Russia’s Healthcare Market Gives Generic Sales Opportunities
5.6.5 India: Generic Manufacturers Seek to Dominate the PD Market
5.6.6 China’s Ageing Population Stimulates Sales of PD-Treating Medicines
6. Research and Development for Treating Parkinson’s Disease
6.1 New Mechanisms of Action in the Late-Stage R&D Pipeline
6.2 Growing Potential of Marketed Products: Phase IV Studies
6.3 Phase III Clinical Products Promising Potential in the PD market
6.3.1 IPX203 (Impax Laboratories): The New Generation of Levodopa
6.3.2 Newron’s Safinamide Expected Launch in 2020
6.3.3 Pimavanserin: A First-in-Class Treatment for Parkinson’s Disease Psychosis
6.3.4 Istradefylline: A Promising A(2a) Receptor Antagonist
6.3.5 Termination of Preladenant, APromising A(2a) Receptor Antagonist
6.3.6 Levodopa/Carbidopa Intestinal Gel (LCIG)
6.3.7 Can Opicapone Compete with Existing COMT Inhibitors
6.3.8 Pitolisant: Addressing an Unmet Need
6.3.9 Northera: Oral Precursor of Norepinephrine
6.3.10 Targin by Mundipharm
6.3.11 Nurelinfor Levodopa-Induced Dyskinesia
6.3.12 SYN-115/120: Superior to Istradefylline?
6.4 Phase II PD Pipeline: Overview
6.4.1 Glutamatergic Drugs: Main Target for Pipeline Candidates
6.4.2 Fipamezole: Another Promising A(2a) Receptor Antagonist
6.4.3 CVT-301: A Novel Intrapulmonary Approach
6.4.4 DM-1992: Can Compete with Levodopa Reformulations?
6.4.5 The Accordion Pill Carbidopa/Levodopa by Intec Pharma
6.4.6 Orient Addresses Sialorrhoea
6.4.7 NH004: Formulated with a Muco-Adhesive Property
6.4.8 VR040: A Reformulation of Apomorphine
6.4.9 AVP-923: A Novel Approach for LID-PD
6.4.10 PD Giant Orion, Develop a New Levodopa Drug, ODM-101
6.4.11 News for NeuroDerm’s Reformulations
6.5 Phase I and Pre-clinical PD Pipeline: Overview
6.5.1 Vernalis’ A(2a) Receptor Antagonist Drug in Phase Ib/IIa
6.5.2 Sanofi Collaborates with The Michael J. Fox Foundation
6.5.3 UCL Show Exenatide Potential in Parkinson’s
6.5.4 Titan Pharmaceuticals Develop a Novel Platform
6.6 Neuroprotective Drugs Offer Hope
6.6.1 Phytopharm and Cogane Development
6.6.2 The Potential of Dietary Supplements
6.6.3 GCase Enzymes: Amicus and Biogen Strike A Deal for Parkinson’s
6.6.4 Research Finds Ursodeoxycholic Acid (UDCA) A Potential Cure for Parkinson’s
6.6.5 PD Biomarkers: Potential for Revolutionising Diagnosis and Treatment
6.6.6 Antibody Targeting: The Coming of Age
6.7 Gene Therapy: Promising Research and Technology
6.7.1 ProSavin: Leading Gene Therapy Product
6.7.2 CERE-120 Promises Repair of Damaged Dopaminergic Neurons
6.7.3 AAV-hAADC-2: Another Gene Therapy Contender
6.8 Parthenogenesis (International Stem Cell Corporation): A Promising Outlook for PD Technology
7. Qualitative Analysis of the PD Drug Market, 2016
7.1 SWOT Analysis of the PD Market
7.1.1 Strengths and Weaknesses in the PD Drug Industry in 2016
7.1.2 Opportunities and Threats There from 2016 Onwards
7.2 STEP Analysis of the PD Market
7.2.1 Social Implication of Living with PD
7.2.2 Technological Developments on the Horizon
7.2.3 Economic Pressures: Healthcare Budgeting
7.2.4 Political Issues: Patent Challenges, Data Exclusivity and Regulatory Pathways
8. Research Interviews
8.1 Interview with Dr. Russell Kern (Executive VP, Chief Scientific Officer): International Stem Cell Corporation, California, US
8.1.1 The Overall PD Market
8.1.2 Current Understanding of Stem Cell Therapy
8.1.3 ISCO’s Novel PD Programme
8.1.4 The Potential of Immune-Matching
8.1.5 The Controversy Surrounding Stem Cell Research
8.1.6 The Potential for Parthenogenesis in PD and Other Applications
8.2 Professor Jian Feng PhD, Department of Physiology and Biophysics, University at Buffalo, the State University of New York
8.2.1 A possible Cure
8.2.2 Future Potential: Research
9. Conclusions from the Research and Analysis
9.1 The World PD Market: Predictions to 2026
9.2 Which Therapeutic Class will Dominate the Market in 2026?
9.3 Disease Modification: The Ultimate Goal
9.4 The Future of the Industry and Market for Parkinson’s Medicines
【レポート販売概要】
■ タイトル:パーキンソン病治療薬の世界市場2016-2026■ 英文:Parkinson’s Diseases: World Drug Industry and Market 2016-2026
■ 発行日:2016年5月
■ 調査会社:visiongain
■ 商品コード:VGAIN60623
■ 調査対象地域:グローバル
- アメリカのフットボール用品市場2016-2020About American Football American football evolved from the soccer and rugby. It is the most popular sport in the US. Its presence is not very strong in other countries, apart from Canada. Professional tournaments in the US are organized by the National Football League (NFL). This sport is also most played by high school and college athletes in the US. Each team has 11 players on the ground at any …
- ITトレーニングの世界市場2015-2019About IT Training IT training refers to the professional training offered by universities, enterprises, and non-formal professional institutes that comprise of B2C (business-to-consumer), B2G (business-to-government), and B2B (business-to-business) training. More number of institution have begun to offer informal and social learning platforms to teach IT, which has changed the learning landscape o …
- 調達アウトソーシングサービスの世界市場展望2017-2026According to Stratistics MRC, the Global Procurement Outsourcing Services market is accounted for $2856.72 billion in 2017 and is expected to reach $9437.63 billion by 2026 growing at a CAGR of 14.2% during the forecast period. The need to adhere to regulatory guidelines and ensure compliance and emergence of nearshore and offshore outsourcing locations are some key factors propelling the growth o …
- グローバル技術トレンドレポート:ビックデータ及び情報処理(Global Technology Trends Report: Big Data and Extreme Info Processing)Big Data represents more than just a collection of data sets that form a large quantity of data, which is difficult to process using traditional data processing applications. Big Data also represents a big business opportunity across many industry verticals. This report provides comprehensive analysis of big data in several key industry verticals including healthcare, government and telecommunicat …
- カナダの心臓律動管理(CRM)装置市場見通しCanada Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "Canada Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the Canada Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resynchronisation Therapy (CRT …
- 家庭用防犯カメラの世界市場展望2017-20276According to Stratistics MRC, the Global Home Security Cameras Market is accounted for $2.76 million in 2017 and is expected to reach $8.78 million by 2026 growing at a CAGR of 13.7% during the forecast period. Some of the key factors influencing the market growth include growing adoption of smart homes, increasing awareness regarding security and safety and ease of installation of security camera …
- 世界の艦艇及び水上戦闘艦艇市場(2014-2024):競争環境、戦略的インサイトSynopsis This report shows the leading Naval Vessels and Surface Combatants market segments in various regions across the world. Details of top companies active across the global Naval Vessels and Surface Combatants market are provided, together with market size and forecast 2014-2024 for the main players across those areas. Summary The report provides a detailed analysis of the competitive landsc …
- 電気泳動装置の世界市場:1D/2Dゲル電気泳動、アガロースゲル電気泳動、ポリアクリルアミドゲル電気泳動、キャピラリー電気泳動、電気泳動試薬Electrophoresis is an analytical method frequently used in molecular biology and medicine. It is extensively used for the separation and characterization of proteins and nucleic acids for genomics and proteomics research. Electrophoresis techniques have become an integral part of life sciences research due to the growing demand for next-generation sequencing, personalized medicine, and structure-b …
- 世界におけるコーキング精製(Coking Refining)市場動向2014Global Coking Refining Industry Outlook, 2014 - Capacity Analysis, Forecasts and Details of All Active and Planned Coking Refineries Summary GlobalData’s energy offering, “Global Coking Refining Industry Outlook, 2014 - Capacity Analysis, Forecasts and Details of All Active and Planned Coking Refineries” is the essential source for industry data and information relating to the refining industry in …
- 世界主要国の無煙たばこ市場Summary “Smokeless Tobacco Key Markets” is the result of ERC’s extensive market research covering the smokeless tobacco market of twenty major countries which include Belgium, Canada, Czech Republic, Finland, France, Hungary, India, Japan, Netherlands, South Africa, Switzerland, Denmark, Germany, Italy, Norway, Poland, Spain, Sweden, the UK and the USA. It provides an analysis of changing consumpt …
- 音楽出版の世界市場2015-2019About music publishing Music publishing involves music recording, merchandizing, publishing, and distributing musical content. To publish the musical content, music publisher requires a copyright of the song along with fee, which is commonly known as royalty. Music publishers are strong intermediaries between songwriters and recording companies. The global music publishing market is highly fragmen …
- ヒトマイクロバイオーム(微生物)の世界市場:プロバイオティクス、プレバイオティクス、食品、医療食、デバイス、薬などNeed for early diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest share of the human microbiome market in the coming years. The high growth in this segment is attributed to the expectations to bring promising microbiome products to the market to help individual …
- 急性リンパ球/リンパ芽球性白血病 (ALL)治療法の世界市場:薬別(ハイパーCVADレジメン、リンカーレジメン、ヌクレオシド代謝阻害剤、標的薬物および免疫療法、CALGB 8811レジメン、およびオンカスパー)、種類別(小児および成人)The global acute lymphocytic/lymphoblastic leukemia therapeutics market accounted for $2,334.5 million in 2018, and is expected to reach $3,528.8 million by 2026, registering a CAGR of 5.3% from 2019 to 2026. There has been a steady rise in the incidences of acute lymphoblastic leukemia (ALL) and the number of bone marrow biopsies across the world. Moreover, focus on R&D of leukemia therapeutics h …
- マスク検査装置の世界市場:技術別、エンドユーザー別、地域別Global Mask Inspection Equipment Market: About this market Technavio’s mask inspection equipment market analysis considers sales from captive mask shops and merchant mask shop end-users. Our study also finds the sales of mask inspection equipment in APAC, the Americas, and EMEA. In 2019, the captive mask shops segment had a significant market share, and this trend is expected to continue over the …
- 血液検査およびフローサイトメトリー市場:主要サプライヤー分析This report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 30 pages